Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1999
10/14/1999WO1999042075A3 Antibodies against human cd40
10/14/1999WO1999036090A9 Oral delivery of nucleic acid vaccines by particulate complexes
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999CA2327185A1 Pyrazole inhibitors of cytokine production
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326739A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326139A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325523A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999CA2325340A1 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325007A1 Human galactosyl transferases
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999CA2324983A1 Hiv-specific cytotoxic t-cell responses
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948614A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds
10/13/1999EP0948319A2 Encapsulated cells producing antibodies
10/13/1999EP0828503A4 Treatment for inhibiting the progression of autoimmune disease
10/13/1999EP0710233B1 Heteroaryl cycloalkenyl hydroxyureas
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/13/1999CN1045539C CDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophie cellular growth
10/12/1999US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis
10/12/1999US5965712 A trimeric protein with an isoleucine zipper configuration and an extracellular domanin of cd23; interacts strongly with immunoglobulin e; antihistamines, antiallergens
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965582 Antihistamines
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965563 Aryl and heteroaryl purine compounds
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965550 Process for the preparation of 4-amino-Δ4 -3-ketosteroids via 4-nitro-Δ4 -3-ketosteroids
10/12/1999US5965532 Low molecular weight, synthetic crosslinking boron compounds as an agonists or antagonists and induce association between naturally occurring receptors, t cell surface receptor
10/12/1999US5965455 Ryegrass pollen allergen
10/12/1999US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965405 Making recombinant antibodies containing the light and heavychain variable domains by transforming cells with an operon having a dna sequence which codes for only the variable domains, culturing and collecting expressed protein
10/12/1999US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999US5965390 Protein L and hybrid proteins thereof
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965381 A mutant strain deficient in producing functional effector proteins; used for heterologous protein transfer into antigen presenting cells; treating infections by pathogens; inducing cellular immune response
10/12/1999US5965140 Hybrid particle immunogens
10/12/1999US5965139 Chicken infectious anemia virus vaccine
10/12/1999CA1340785C Platelet activating factor antagonists
10/07/1999WO1999050396A1 Nek1-related protein kinase
10/07/1999WO1999050394A1 Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
10/07/1999WO1999050392A1 Methods and compositions for eliciting an immune response to a telomerase antigen
10/07/1999WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050282A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999WO1999050262A1 Pde iv inhibiting pyridine derivatives
10/07/1999WO1999050253A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/07/1999WO1999050250A1 Hiv inhibiting pyrimidine derivatives
10/07/1999WO1999050248A1 Pyridazinone hydrochloride compound and method for producing the same
10/07/1999WO1999050245A1 Indole derivatives with antiviral activity
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999WO1999049889A1 Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049881A2 Application of hsp70 proteins
10/07/1999WO1999049863A1 Sustained release preparations
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999WO1999049843A1 Solid, quick dissolving cetirizine formulations
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999WO1999024077A3 Compositions and methods for targeted delivery of biologically-active factors
10/07/1999DE19814905A1 Verwendung von Bärentraubenblätter (Arctostaphylos uva ursi)-, Birkenblätter (Betula)-, Schachtelhalmkraut (Equisetum)- und Brennessel (Urtica)-Extrakten Use of bearberry leaves (Arctostaphylos uva ursi) -, birch leaves (Betula) - Horsetail (Equisetum) - and stinging nettle (Urtica) extracts
10/07/1999DE19814725A1 Verwendung von Echinacea-pallida und Echinacea angustifolia-Extrakten; Use of Echinacea pallida and Echinacea angustifolia extracts; Löwenzahn-/Taraxacum)-Extrakten; Dandelion / Taraxacum) extracts; Spitzwegerich-(Plantago)-Extrakten Spitzwegerich- (Plantago) extracts
10/07/1999DE19814256A1 Feste, schnellzerfallende Cetirizin-Formulierungen Solid rapidly disintegrating cetirizine formulations
10/07/1999DE19813760A1 Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases
10/07/1999CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999CA2326506A1 Pyridazinone hydrochloride compound and method for producing the same
10/07/1999CA2326166A1 Indole derivatives with antiviral activity
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
1 ... 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 ... 1172